Research Commercialization Academy (BETA 0.01)

Back Office Services for NCET2.org

 
NIH Webinar on New Programs to Accelerate Drug Discovery PDF Print E-mail



University-Industry Demonstration Partnership (UIDP)

and the National Institutes of Health

Present

NIH Webinar on New Programs to Accelerate Drug Discovery
Tuesday, March 27, 2012, 1:00 pm to 2:30 pm ET

Download Slides here




ABOUT THIS WEBINAR:

Researchers in academia and small businesses often lack the resources to develop novel therapeutics to the point where they can attract private financing. This webinar will highlight new, innovative programs at the National Institutes of Health (NIH) designed to accelerate drug discovery for neurological conditions in universities, non-profit research organizations, and companies. The first half of the webinar will focus on the NIH Blueprint Neurotherapeutics Network (BPN). The BPN offers access to a ‘virtual pharma’ with resources, expertise, and funding to advance promising compounds from the stages of early chemical optimization through phase I clinical testing. Similar to most grant programs at NIH, the BPN is structured so that participants retain ownership of the intellectual property for drugs developed during the program. The second half of the webinar will spotlight new opportunities for small businesses within the Small Business Innovation Research (SBIR) program. The National Institute for Neurological Disorders and Stroke (NINDS) has several new Funding Opportunity Announcements (FOAs) specifically targeted to support preclinical research and clinical trials.


ABOUT THE PRESENTERS:

Rebecca Farkas, Ph.D.
Program Director in the Office of Translational Research (OTR)
National Institute of Neurological Disorders and Stroke (NINDS)

Dr. Rebecca Farkas is a Program Director in the Office of Translational Research (OTR) at the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Farkas is one of the leaders of the NIH Blueprint Neurotherapeutics Network, a “virtual pharma” for advancing drug discovery projects from the validated hit stage through phase I clinical testing. She also oversees translational research training initiatives and programs for early-stage translational research. Dr. Farkas received her Ph.D. in Developmental Biology at Stanford University School of Medicine and her B.A. in Molecular Biophysics and Biochemistry from Yale University. She served as a science policy analyst in the NINDS Office of Science Policy and Planning for seven years before joining OTR.


Stephanie Fertig, M.B.A.
Research Project Manager, Office of Translational Research (OTR)
National Institute of Neurological Disorders and Stroke (NINDS)

Ms. Stephanie Fertig is the Research Project Manager for small business programs in the Office of Translational Research (OTR) at the National Institute of Neurological Disorders and Stroke (NINDS). Ms. Fertig manages both the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which are congressionally mandated set-aside programs specifically for small business concerns. In addition, she serves as the project officer for the majority of the SBIR and STTR grants assigned to NINDS. Prior to joining OTR, Ms. Fertig was a member of the Repair and Plasticity cluster in the NINDS Division of Extramural Research. Ms. Fertig received her M.B.A from the University of Maryland’s Robert H. Smith School of Business and her B.S. in Chemistry with a major in Physics from the University of Virginia.


IMPORTANT INFORMATION FOR ATTENDEES:

WEBINAR DURATION: Each session is a 90-minute webinar with 60 minutes of presentation and 30 minutes of Q&A.

COST: Free, but registration required by clicking on register the Register button above. Your registration is valid for all webinars in this series

HOW TO PARTICIPATE?: This webinar is online. You need a computer with web access for the visual/audio. You may also dial-in using the audio-only telephone number. The call in details and instructions on how to join the webinar will be sent to you via email after you register. Once registered to the webinar you will receive a reminder email 24 hours before the start of the webinar with instructions on how to join.

QUESTIONS TO SPEAKERS: Q&A is conducted by a chat box to the speakers.

WHO SHOULD PARTICIPATE IN THE WEBINAR?: University officials, researchers looking to commercialize research, federal and state government officials, venture capitalists, angel investors, Global 1000 companies, industry representatives, entrepreneurs and individual investors.

SLIDES AND VIDEO: The slide presentations and video recording will be available on this page. If you are unable to join the live webinar, you may view the recorded video that will be posted within 24 hours after the scheduled webinar ends.

 

* While the University-Demonstration Partnership (UIDP) is pleased to be a sponsor of this webinar series in concert with NCET2, the views expressed are those of the presenters and not necessarily those of UIDP, its National Academies sponsor, the Government-University-Industry Research Roundtable (GUIRR), or the National Academies.